Light-adjustable IOLs provide stable outcomes

Article

Light-adjustable intraocular lenses (IOLs) provide near-emmetropic refractive outcomes and good uncorrected distance visual acuity that remains stable over time, according to a recent study.

Light-adjustable intraocular lenses (IOLs) provide near-emmetropic refractive outcomes and good uncorrected distance visual acuity that remains stable over time, according to a study published in the Journal of Cataract and Refractive Surgery.

Researchers at University Hospital Virgen de la Arrixaca, Murcia, Spain, performed a prospective non-randomized clinical trial of 53 eyes in 49 patients that had been implanted with a light-adjustable IOL. The researchers used spatial intensity profiles to correct refractive errors in the eyes, and estimated the effective changes in the IOLs' refraction after every treatment by subtracting those in the whole eye and the cornea.

After every light treatment and at 3-, 6- and 12-months, the researchers measured the refractive changes in the whole eye, refractive changes in the IOL, manifest refraction and visual acuity.

A maximum change in spherical power of the light-adjustable IOL of between −1.98 D and +2.30 D was induced by the combination of 2 light adjustments. In astigmatism the maximum change was up to −2.68 D. Axis errors were below 9 degrees. A small myopic shift of +0.01 to +0.57 D was produced by the 2 'lock-in' procedures.

To read an abstract of the study, click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.